Medication Type for T2DM May Affect Severe COVID-19 Outcomes
Premorbid GLP1-RA use, SGLT2i use associated with lower 60-day mortality compared to premorbid DPP4i use
Drop Seen in Physician Work Hours During COVID-19 Pandemic
Full-time status significantly declined among female physicians with preschool-aged children
16.8 Million Undiagnosed COVID-19 Cases in First Six Months in U.S.
Overall weighted undiagnosed seropositivity estimate was 4.6 percent, with estimates ranging from 1.1 to 14.2 percent by subgroup
Most Americans Who Wanted COVID-19 Vaccine Have Already Gotten One
Only 3 percent of those who have not been vaccinated said they plan to do so as soon as they can
33 Million Persons of All Ages Uninsured in 2019
3.7 million (5.1 percent) children and 28.8 million (14.5 percent) working age adults were uninsured in 2019
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
LA County Recommends Masks for All When Indoors as Delta Variant Spreads
First identified in India, the Delta variant is now the third-most common in California
Seven Cases of Guillain-Barré Noted After COVID-19 Vaccine in India
Second study describes four cases, which occurred 11 to 22 days after vaccination with COVID-19 Oxford-AstraZeneca vaccine
Less Than 1 Percent of COVID-19 Patients Experience Reinfection
Symptoms of severe disease less frequent with reinfection, although death can occur
Care Disparities Seen for COVID-19 Patients With, Without Schizophrenia
Increased in-hospital mortality for COVID-19 patients with schizophrenia versus those without severe mental illness
